• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    2/10/23 1:22:43 PM ET
    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Beverages (Production/Distribution)
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABEV alert in real time by email

     

    During Friday, 48 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Ambev (NYSE:ABEV).
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Soligenix (NASDAQ:SNGX) shares traded down 1193.45% to reach its 52-week low, making it the biggest loser.
    • Vertical Aerospace (NYSE:EVTL) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Ambev (NYSE:ABEV) stock achieved a new 52-week low on Friday morning, hitting $2.41 and moving down 1.43%.
    • Bank Bradesco (NYSE:BBD) stock hit a yearly low of $2.43. The stock was down 6.98% for the day.
    • Sirius XM Holdings (NASDAQ:SIRI) shares were down 0.42% for the day, having made a 52-week low of $4.72.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.60. The stock traded down 0.79%.
    • Sterling Check (NASDAQ:STER) shares set a new yearly low of $11.92 this morning. The stock was down 11.46% on the session.
    • Cronos Group (NASDAQ:CRON) shares made a new 52-week low of $2.26 on Friday. The stock was down 1.72% for the day.
    • Mercer Intl (NASDAQ:MERC) shares fell to $10.55 on Friday, setting a new 52-week low with a shift of down 10.52%.
    • Azul (NYSE:AZUL) stock hit $5.19 on Friday morning, setting a new 52-week low for a change of down 4.59%.
    • Vertical Aerospace (NYSE:EVTL) stock hit a yearly low of $1.94. The stock was 0.0% (flat) for the day.
    • Bridger Aerospace Gr (NASDAQ:BAER) stock hit a new 52-week low of $3.77. The stock was down 2.18% on the session.
    • Guaranty Bancshares (NASDAQ:GNTY) shares hit a yearly low of $31.10. The stock was up 0.09% on the session.
    • Hyzon Motors (NASDAQ:HYZN) shares reached a new 52-week low of $1.25 on Friday morning, moving down 23.94%.
    • Tupperware Brands (NYSE:TUP) shares reached a new 52-week low of $3.72 on Friday morning, moving down 1.28%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) shares fell to $1.10 on Friday, setting a new 52-week low with a shift of down 6.38%.
    • GreenLight Biosciences (NASDAQ:GRNA) stock hit $0.86 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a yearly low of $2.04. The stock was down 6.11% for the day.
    • Clough Global Equity (AMEX:GLQ) shares hit a yearly low of $6.14. The stock was up 0.33% on the session.
    • Vintage Wine Estates (NASDAQ:VWE) stock achieved a new 52-week low on Friday morning, hitting $1.85 and moving down 5.48%.
    • Heliogen (NYSE:HLGN) stock set a new 52-week low of $0.38 on Friday, moving down 8.33%.
    • NeoVolta (NASDAQ:NEOV) shares set a new yearly low of $1.96 this morning. The stock was down 7.11% on the session.
    • Taysha Gene Therapies (NASDAQ:TSHA) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 2.38%.
    • P3 Health Partners (NASDAQ:PIII) stock achieved a new 52-week low on Friday morning, hitting $1.05 and moving down 4.0%.
    • 9F (NASDAQ:JFU) stock dropped to a yearly low on Friday of $3.13. Shares traded down 8.92%.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares moved down 2.09% on Friday to hit a new 52-week low of $0.80, drifting down 2.09%.
    • MGO Global (NASDAQ:MGOL) shares set a new 52-week low of $1.79. The stock traded down 9.05%.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock broke to a new 52-week low of $1.86 on Friday. Shares of the company traded down 0.1%.
    • CN Energy Group (NASDAQ:CNEY) shares set a new yearly low of $0.41 this morning. The stock was down 6.33% on the session.
    • Can Fite Biofarma (AMEX:CANF) shares set a new yearly low of $3.35 this morning. The stock was down 4.23% on the session.
    • WiSA Technologies (NASDAQ:WISA) stock achieved a new 52-week low on Friday morning, hitting $5.99 and moving down 4.31%.
    • Tenax Therapeutics (NASDAQ:TENX) shares fell to $1.03 on Friday, setting a new 52-week low with a shift of down 2.73%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares reached a new 52-week low of $1.23 on Friday morning, moving down 7.95%.
    • OceanPal (NASDAQ:OP) stock hit a new 52-week low of $0.62. The stock was down 10.98% on the session.
    • OpGen (NASDAQ:OPGN) stock hit a new 52-week low of $1.45. The stock was down 4.97% on the session.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.18 on Friday morning, moving down 1.76%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares hit a yearly low of $5.10. The stock was down 5.06% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ABEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $ALLR
    $ASTI
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Ambev S.A.
    $ABEV
    11/26/2025Outperform → Mkt Perform
    Bernstein
    Taysha Gene Therapies Inc.
    $TSHA
    10/21/2025$13.00Strong Buy
    Raymond James
    Banco Bradesco Sa
    $BBD
    10/14/2025Sell → Neutral
    Goldman
    NeoVolta Inc.
    $NEOV
    10/1/2025Buy → Hold
    Maxim Group
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Ambev S.A.
    $ABEV
    8/1/2025Buy → Hold
    HSBC Securities
    More analyst ratings

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AmBev downgraded by Bernstein

    Bernstein downgraded AmBev from Outperform to Mkt Perform

    11/26/25 8:31:27 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    Raymond James initiated coverage on Taysha Gene Therapies with a new price target

    Raymond James initiated coverage of Taysha Gene Therapies with a rating of Strong Buy and set a new price target of $13.00

    10/21/25 7:22:35 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Banco Bradesco upgraded by Goldman

    Goldman upgraded Banco Bradesco from Sell to Neutral

    10/14/25 8:35:27 AM ET
    $BBD
    Major Banks
    Finance

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SiriusXM to Report Fourth Quarter and Full-Year 2025 Operating and Financial Results

    NEW YORK, Jan. 6, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) will release its fourth quarter and full-year 2025 operating and financial results on Thursday, February 5, and will hold an investor call that same day at 8:00 a.m. ET. A live webcast of the call will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com. To participate by telephone, please dial 1.877.407.4019 (Toll-free) or 1.201.689.8337 (Local) 10 minutes prior to the start of the call and ask to be connected to the SiriusXM conference call. About Sirius XM Holdings Inc.SiriusX

    1/6/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome

    First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across multiple sites Reached written alignment with FDA on inclusion of ≥3 months of safety data from ASPIRE trial evaluating TSHA-102 (N=3, aged 2 to <4 years) in planned BLA submission to support a broad label in patients aged ≥2 years with Rett syndrome Completion of dosing in REVEAL pivotal trial and ASPIRE trial expected in Q2 2026 Longer-term safety and efficacy data update from Part A of REVEAL Phase 1/2 trials expected in H1 2026 DALLAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-s

    1/6/26 8:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

    TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today issued the following letter to shareholders from the Company's Chief Executive Officer.Dear Shareholders, As we close out 2025, I write to you with both optimism and gratitude. Your continued support has helped steer Allarity Therapeutics through a period of meaningful transformation and disciplined execution. This December marks two years since I assumed the role of Chief Executive Officer. Since that time, our efforts have bee

    12/31/25 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Coughlin Zachary

    3 - SIRIUS XM HOLDINGS INC. (0000908937) (Issuer)

    1/5/26 4:28:10 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    CEO Witz Jennifer C covered exercise/tax liability with 12,406 shares, decreasing direct ownership by 5% to 242,301 units (SEC Form 4)

    4 - SIRIUS XM HOLDINGS INC. (0000908937) (Issuer)

    1/2/26 4:49:02 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Chief Financial Officer Szot Matthew K sold $69,233 worth of shares (9,933 units at $6.97), closing all direct ownership in the company (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    12/31/25 4:05:19 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Rich Stuart bought $50,792 worth of shares (5,000 units at $10.16), increasing direct ownership by 90% to 5,266 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/10/25 6:48:57 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Kellogg Peter R bought $1,879,939 worth of shares (1,014,540 units at $1.85), increasing direct ownership by 6% to 646,000 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    12/9/25 8:09:58 PM ET
    $MERC
    Paper
    Basic Materials

    Chief Medical Officer Rich Stuart bought $45,622 worth of shares (5,000 units at $9.12), increasing direct ownership by 940% to 2,766 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/5/25 5:46:32 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    SEC Filings

    View All

    SEC Form S-8 filed by Taysha Gene Therapies Inc.

    S-8 - Taysha Gene Therapies, Inc. (0001806310) (Filer)

    1/6/26 4:37:54 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form N-CSR filed by Clough Global Equity Fund Clough Global Equity Fund

    N-CSR - Clough Global Equity Fund (0001316463) (Filer)

    1/6/26 2:17:00 PM ET
    $GLQ
    Finance/Investors Services
    Finance

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    1/5/26 4:30:05 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Books Over $1.1M in CHECKLIGHT® Software Sales -

    One of the Nation's Largest Religious Institutions Renews and Expands via a Three-Year Contract Scottsdale, AZ, Dec. 17, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced it has booked more than $1.1 million in CHECKLIGHT® software sales, highlighted by the renewal and expansion of a three-year agreement with one of the nation's largest religious institutions. The institution has relied on CHECKLIGHT® for more than four years, amassing over 100 million hours of protected operations with zero breaches and zero financial claims. The renewed and expanded multi-year contract deepens the institu

    12/17/25 4:30:00 PM ET
    $CISO
    Professional Services
    Consumer Discretionary

    CISO Global Announces Strong Results from Annual Shareholder Meeting - Positioned for Growth and Transformation

    Scottsdale, AZ, Dec. 16, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced the successful results of its Annual Shareholder Meeting, highlighted by strong shareholder participation and overwhelming support for the Company's leadership, strategy, and governance initiatives. More than 66% of outstanding shares were represented and voted at the meeting, reflecting robust shareholder engagement and confidence in the Company's direction. All nominees to the Board of Directors were re-elected with at least 95% approval, reaffirming strong support for the Board's oversight and leadership. Over the

    12/16/25 5:30:00 PM ET
    $CISO
    Professional Services
    Consumer Discretionary

    Universal Background Screening Appoints Val Poltorak as President, Signaling New Era of Client-Focused Growth and Industry Innovation

    Universal Background Screening (UBS), a leading provider of background screening and compliance solutions, today announced the appointment of Val Poltorak as President. Poltorak brings an extensive background in SaaS, FinTech, and regulated industries, along with a distinguished record of driving growth, operational excellence, and customer-centric innovation across dynamic, compliance-driven markets. Poltorak joins UBS following an accomplished tenure at Sterling (NASDAQ:STER), where she helped scale the company's Healthcare division into its largest business unit and later led the Regulated Industries Division. During her leadership, Sterling achieved major growth milestones, strengthene

    12/10/25 8:00:00 AM ET
    $STER
    EDP Services
    Technology

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Financials

    Live finance-specific insights

    View All

    SiriusXM to Report Fourth Quarter and Full-Year 2025 Operating and Financial Results

    NEW YORK, Jan. 6, 2026 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) will release its fourth quarter and full-year 2025 operating and financial results on Thursday, February 5, and will hold an investor call that same day at 8:00 a.m. ET. A live webcast of the call will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com. To participate by telephone, please dial 1.877.407.4019 (Toll-free) or 1.201.689.8337 (Local) 10 minutes prior to the start of the call and ask to be connected to the SiriusXM conference call. About Sirius XM Holdings Inc.SiriusX

    1/6/26 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

    Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing it from related compounds.Orphan Drug and Fast Track designations from the FDA PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition of VLX-1005 and related 12-lipoxygenase (12-LOX) assets from Veralox Therapeutics ("Veralox"). The acquisition immediately strengthens Cadren

    12/11/25 8:05:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertical Aerospace Insiders Increase Their Shareholding in EVTL by 50% in November

    Majority shareholder Mudrick Capital also acquires 350,000 additional shares Share purchases underscore leadership's strong confidence in long-term value creation Near-term milestones include completion of Phase 4 Transition Flight and unveiling of its new full-size aircraft that it will take through to certification Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL) today announced that 16 members of its Board of Directors and senior leadership team completed open-market purchases of the Company's ordinary shares over a two-week open trading window period in November 2025. These share purchases follow a series of open market share purchases by Vertical Chairman Dómhnal Slatte

    12/1/25 7:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary